odronextamab,epcoritamab
regeneron,genmab,abbvie
['kudos', 'odronextamab', 'epcoritamab', 'lymsm']
2 more cd20/cd3 bi-specifics- epcoritamab + r-dhax/c and odronextamab are showing promising safety and efficacy results! #ashkudos to all investigators! #ash22 #lymsm
Hematologist/Oncologist/BMT Cell therapy @UNC_Lineberger . Proud grad ???????@MontefioreNYC @EinsteinMed @slrchiefs @nairtnmc | Wife to @abhinav_gupta91 | Mom